Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
India
· Delayed Price · Currency is INR | Market Cap | 1.06T |
| Revenue (ttm) | 115.16B |
| Net Income (ttm) | 19.11B |
| Shares Out | n/a |
| EPS (ttm) | 56.47 |
| PE Ratio | 55.45 |
| Forward PE | 42.44 |
| Dividend | 32.00 (1.01%) |
| Ex-Dividend Date | Jan 31, 2025 |
| Volume | 352,852 |
| Average Volume | 350,288 |
| Open | 3,153.00 |
| Previous Close | 3,174.70 |
| Day's Range | 3,102.00 - 3,160.00 |
| 52-Week Range | 2,570.45 - 3,590.70 |
| Beta | 0.17 |
| RSI | 39.95 |
| Earnings Date | May 23, 2025 |
About Torrent Pharmaceuticals
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and dermatology, diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company... [Read more]
Financial Performance
In 2024, Torrent Pharmaceuticals's revenue was 115.16 billion, an increase of 7.35% compared to the previous year's 107.28 billion. Earnings were 19.11 billion, an increase of 15.37%.
Financial StatementsNews
Pharma stocks rally: Glaxo surges 7%, Torrent gains after Q4; Gland steady post mixed results
Pharma stocks were trading firmly in the green on Tuesday morning, with GlaxoSmithKline Pharmaceuticals leading the charge—rising 7.4% to ₹2,992.80 as of 10:05 AM. The broader sector saw widespread bu...
Torrent Pharma shares jump 3% as Q4 EBITDA rises 9.2% YoY to Rs 964 crore
Torrent Pharmaceuticals shares jumped over 3% in morning trade following robust Q4FY24 earnings. As of 9:27 AM, the shares were trading 3.17% higher at Rs 3,344.20, The company reported a net profit o...
Torrent Pharma share price: Nomura sees 11% upside, maintains neutral after Q4 miss due to one-off
Nomura has maintained a neutral rating on Torrent Pharmaceuticals, with a target price of ₹3,580, suggesting a modest upside of nearly 11% from the current market price of ₹3,233.10. The brokerage fla...
Torrent Pharma share price: Nuvama expects 16% upside, cites India, US growth and semaglutide launches
Nuvama Institutional Equities has maintained its buy rating on Torrent Pharmaceuticals with a target price of ₹3,760, citing steady Q4 performance and strong growth prospects across geographies. While...
Aman Mehta to lead Torrent Pharma in generational transition
Ahmedabad: Passing the baton while powering ahead — Torrent Pharmaceuticals is entering a new chapter as Aman Mehta, next-gen scion of the Mehta famil.
Torrent Pharmaceuticals issues Rs 300 crore worth of commercial papers at 7.13% discount rate
Torrent Pharmaceuticals Limited has issued commercial papers worth Rs 300 crore on March 25, 2025, as part of its short-term funding plans. The instruments have a tenure of 90 days and are set to matu...
Torrent Pharmaceuticals Ltd (BOM:500420) Q3 2025 Earnings Call Highlights: Strong India Growth ...
Torrent Pharmaceuticals Ltd (BOM:500420) Q3 2025 Earnings Call Highlights: Strong India Growth and Strategic Challenges
Q3 2025 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Q3 2025 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Top Q3 Results Tomorrow, January 24: HPCL, JSW Steel, IndiGo, Torrent Pharma, Godrej Consumer Products, Shriram Finance and more
The earnings season continues to heat up as several major companies are set to report their Q3FY25 results tomorrow. Among the highlights, the key companies to keep an eye on include Torrent Pharmaceu...
Pharma stocks weekly roundup: Biocon leads with 9.08% gain, Torrent Pharma up 4.91%, Lupin dips 1.82%
The pharmaceutical sector experienced diverse movements during the week of November 25–29, 2024. Among the notable performers, Biocon Ltd led the gains with a significant surge of ₹30.35 (9.08%), clos...
Torrent Pharmaceuticals market cap rises Rs 3,450 crore
Torrent Pharmaceuticals saw its stock price rise by 3.19% to Rs 3,305.00 in today’s trading session. This price surge contributed to an increase of Rs 3,450 crore in the company’s market capitalizatio...
Torrent Pharma receives EIR from USFDA for Pithampur facility
Torrent Pharmaceuticals has announced that it has received an Establishment Inspection Report (EIR) from the USFDA for its manufacturing facility in Pithampur, Madhya Pradesh. The inspection, conducte...
Torrent Pharma shares rise nearly 3% after receiving EIR from USFDA
Shares of Torrent Pharmaceuticals climbed 2.54% to trade at ₹3,180.65 as of 12:16 PM on November 22. The surge comes after the company announced it has received an Establishment Inspection Report (EIR...
Torrent Pharma Block Deal: 1.04 crore shares or 3% equity worth Rs 3,230 crore change hands
Torrent Pharmaceuticals shares dropped 3.15% to ₹3,114.35 as of 9:19 am on the NSE after a significant large trade. Approximately 1.04 crore shares, equating to 3.1% of equity, exchanged hands at ₹3,1...
Stock to watch today: Torrent Pharma promoter to sell up to 2.9% stake via block deal: Report
Torrent Pharmaceuticals Ltd. is likely to be in focus today as promoter entity Torrent Investments has announced plans to sell up to a 2.9% stake in the company through a block deal. This information ...
Torrent Pharmaceuticals shares in focus as Q2 profit rises 17.4% to ₹453 crore
Torrent Pharmaceuticals has attracted attention after reporting a 17.4% increase in net profit for the second quarter, rising to ₹453 crore. The company’s revenue grew by 8.6%, reaching ₹2,889 crore, ...
Torrent counters faulty drug claim
Torrent Pharmaceuticals Limited strongly denies allegations regarding its Shelcal 500 product, claiming the seized sample is counterfeit and not produced by them. The company has implemented anti-coun...
Torrent Pharma announces US FDA’s inspection conclusion at Madhya Pradesh facility, shares surge over 2%
Torrent Pharmaceuticals announced that the United States Food & Drug Administration (USFDA) conducted a routine GMP inspection at its formulation manufacturing facility in Pithampur, Madhya Pradesh, b...
Torrent Pharma shares surge around 2% after USFDA inspection closure
Torrent Pharmaceuticals (TORNTPHARM) saw its shares increase by 1.96%, trading at ₹3,502.00 at 10:21 AM on the NSE. The stock’s upward movement follows the company’s announcement that its Indrad manuf...
Torrent Pharma’s Indrad facility receives USFDA EIR with VAI Classification
Torrent Pharmaceuticals has announced that its manufacturing facility in Indrad, Gujarat, has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA), with a...